MATRICELF
LIVE

Serial Number

79391456

Owner

Matricelf Ltd.

Attorney

Mark I. Koffsky

Filing Date

Nov 27, 2023

Add to watchlist:

No watchlists yet
View on USPTO

MATRICELF Trademark

Serial Number: 79391456 • Registration: 7741564

MATRICELF is a trademark filed by Matricelf Ltd. on November 27, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Matricelf Ltd.

3 Golda Meir Street

Entity Type: 22

Trademark Details

Filing Date

November 27, 2023

Registration Date

April 1, 2025

Published for Opposition

February 11, 2025

Goods & Services

Biological implants, namely, implants comprising living tissue; biological tissue for implantation, namely, biological tissue grafts, implants comprising living tissue; biological tissue cultures for medical purposes; engineered biological tissues for medical purposes, namely, engineered biological tissue cultures for medical purposes; engineered human biological tissues for use in regenerative medicine, namely, engineered biological tissue cultures for medical purposes for use in regenerative medicine; engineered biological tissues for the treatment of spinal cord injuries, namely, engineered biological tissue cultures for medical purposes for the treatment of spinal cord injuries; biological implants for spinal cord injuries, namely, implants comprising living tissue; bio-printed personalized medical implants comprised of living tissue; a personalized bio-printed medical tissue implant adapted to fill a surgically defined cavity, namely, personalized bio-printed implants comprising living tissue; Transplants, namely, implants comprising living tissue; surgical implants comprising engineered living tissue; surgical implants comprising living tissue grown from stem cells; engineered human hydrogel and differentiated stem cells in the nature of biological tissues in the nature of biological tissue cultures for medical purposes; engineered human hydrogel for medical purposes; stem cells for medical purposes; biomaterials in the nature of biological tissue cells for printing engineered tissues for medical purposes

Regenerative medicine services; medical services, namely, tissue regeneration services; medical services, namely, tissue regeneration services using tissue engineering technology; medical services, namely, cellular therapy services; medical services, namely, regenerating and restoration of spinal cord tissue by means of implanting engineered tissues in the spinal cord; biomedical services, namely, treating human tissues for medical purposes; medical services relating to the removal, treatment and processing of human tissues; medical services relating to the removal, treatment and processing of human tissues for implantation

Scientific services relating to processing human tissues and cells, namely, stem cell production in the nature of development of stem cells and tissue engineering services for processing human tissues and cells; medical and scientific research and development of human tissues and stem cells; medical and scientific research and development in the field of personalized medicine 3D bioprinting; stem cell research services; scientific and technological services in the field of regenerative medicine, namely, medical research, scientific research and development; medical and scientific research and development in the field of regenerative medicine; medical and scientific research and development in the field of spinal cord injuries; pharmaceutical and biological research and development services in the field of tissue regeneration and engineering

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 31, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 14, 2025 FICS
FINAL DISPOSITION PROCESSED
Oct 14, 2025 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Aug 29, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 13, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 13, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 1, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 1, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 1, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 11, 2025 NPUB
PUBLISHED FOR OPPOSITION
Feb 11, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 5, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 22, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 21, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 21, 2025 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jan 21, 2025 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jan 7, 2025 GNFN
FINAL REFUSAL E-MAILED
Jan 7, 2025 GNFR
FINAL REFUSAL WRITTEN
Jan 7, 2025 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 26, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 25, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 25, 2024 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 25, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 25, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 25, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 25, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 25, 2024 COAR
REFUSAL PROCESSED BY IB
Aug 11, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 25, 2024 RFCS
REFUSAL PROCESSED BY MPU
Jul 25, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 30, 2024 RFCR
NON-FINAL ACTION WRITTEN
Jun 29, 2024 CNRT
ASSIGNED TO EXAMINER
Jun 26, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Apr 24, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 20, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 14, 2024 REPR